Also known as: Mantis #1

Mantis Glue

An obscure GG4-adjacent hybrid that circulates among hobby growers, with limited verified breeder documentation.

Sourced and fact-checked
9 cited sources
Published 12 hours ago
How this page was made
↯ The honest take

Mantis Glue is a niche strain name that pops up in seed swaps and small-batch grows, usually described as a GG4 (Gorilla Glue #4) cross. There's no widely documented breeder release, no lab data archive, and no peer-reviewed work on it specifically. Treat anything you read about its 'effects profile' as anecdote from a handful of growers, not established fact. If you're buying seeds or flower under this name, ask the seller for the actual parents and, ideally, a COA.

Overview

Mantis Glue is a hobbyist-circulated cannabis hybrid most often described as a descendant or cross of GG4 (Gorilla Glue #4). It does not appear in major strain databases with a verified breeder release page, and we could not find a peer-reviewed or government source that profiles it No data. What follows is a careful summary of what's claimed about it, with the caveat that almost all of this is grower folklore rather than measured data.

The name 'Mantis' shows up across several unrelated breeding projects (e.g., 'Praying Mantis,' 'Mantis #1'), so be aware that two packs labeled 'Mantis Glue' from different vendors may not be the same plant at all.

Chemistry: cannabinoids and terpenes

There is no published lab dataset for Mantis Glue specifically No data. Vendor listings sometimes cite 20–25% THC, but these numbers are marketing claims, not aggregated COA data.

If the strain truly carries significant GG4 genetics, you'd expect a terpene profile leaning on β-caryophyllene, limonene, and myrcene, which is the pattern documented in GG4 and several of its descendants [1][2] Weak / limited. That's an inference from lineage, not a measurement of Mantis Glue itself.

A reminder: the popular claim that a strain is 'indica' or 'sativa' based on terpene dominance — e.g. 'myrcene above 0.5% means couch-lock' — is folklore, not an established pharmacological threshold [3] Disputed. Terpene concentrations vary enormously between phenotypes, harvests, and cure conditions of the same strain [1].

Reported effects

There are no strain-specific clinical trials for Mantis Glue, and there almost certainly never will be — this is true for nearly every named cannabis strain [4] Strong evidence.

Grower and consumer reports (forum posts, vendor descriptions) typically describe it as heavy, relaxing, and sedating in higher doses, consistent with how GG4 itself is usually described Anecdote. Reported effects in cannabis are driven primarily by dose, THC content, route of administration, individual tolerance, and setting — not by strain name [4][5] Strong evidence. Two people smoking 'the same' Mantis Glue from different growers can have meaningfully different experiences.

If you're using cannabis therapeutically, the strain name is one of the least reliable variables. A current COA showing cannabinoid and terpene content is far more informative.

Lineage (disputed)

The most common claim is that Mantis Glue is GG4 × an unspecified 'Mantis' cut, or GG4 crossed with a Chem/Diesel line. We have not been able to verify a breeder pedigree from a primary, documented source No data.

GG4 itself has a reasonably well-documented origin (a chance seed found by GG Strains, with reported parents of Chem's Sister, Sour Dubb, and Chocolate Diesel) [6]. Anything downstream of GG4 sold under a novel name should ideally come with named parent cuts and breeder notes. If a seller cannot tell you which Mantis Glue line they have or who bred it, treat the lineage as unknown rather than assumed.

Cultivation basics

Based on the assumption (not confirmed) that Mantis Glue behaves like other GG4 descendants:

None of the above is Mantis Glue–specific data. It's a reasonable starting point based on relatives, and you should adjust to your actual phenotype.

Marketing vs. reality

A few honest notes if you see Mantis Glue advertised:

Sources

  1. Peer-reviewed Smith, C. J., et al. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
  2. Peer-reviewed Reimann-Philipp, U., et al. (2020). Cannabis Chemovar Nomenclature Misrepresents Chemical and Genetic Diversity. Cannabis and Cannabinoid Research, 5(3), 215–230.
  3. Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
  4. Peer-reviewed MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12–19.
  5. Peer-reviewed Hindocha, C., et al. (2020). The effects of cannabis on respiratory and behavioural measures: A laboratory study. Journal of Psychopharmacology, 34(11), 1241–1252.
  6. Reported Leafly Staff. 'Gorilla Glue #4: The strain that won and changed its name.' Leafly, 2017.
  7. Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports, 8, 4519.
  8. Reported Schroyer, J. 'Inflated THC potency results plague cannabis industry.' MJBizDaily, 2022.
  9. Peer-reviewed Sawler, J., et al. (2015). The Genetic Structure of Marijuana and Hemp. PLOS ONE, 10(8), e0133292.

How this page was made

Generation history

May 11, 2026
Fact-check pass — raised 2 flags
May 11, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.